Sandesh Mahatme, Director at Crispr Therapeutics AG, holds ― shares in Crispr Therapeutics AG (Ticker: CRSP), holds 0.00 shares in Vor Biopharma (Ticker: VOR), holds 32.27K shares in Sarepta Therapeutics (Ticker: SRPT). Most recently, Sandesh Mahatme ― shares of Crispr Therapeutics AG on ― for an estimated value of ―.
Sandesh Mahatme latest transaction was an Uninformative Buy of ―.
What was Sandesh Mahatme's most profitable transaction?
Sandesh Mahatme’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Sandesh Mahatme's role in Crispr Therapeutics AG?
Sandesh Mahatme's role in Crispr Therapeutics AG is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.